DR. JOHN K. PAGLIA

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Simulations Plus, Inc.

Filing Date Source Excerpt
2017-12-29 Dr. John K. Paglia was appointed as a Director of the Company as of December 3, 2014. He holds a Ph.D. in finance, an MBA, a B.S. in finance, and is a Certified Public Accountant and Chartered Financial Analyst. The Board has three committees: Audit Committee, Compensation Committee, and Nominating Committee. Dr. John K. Paglia serves on all three committees and is the Chair of the Audit Committee. Director Compensation for Fiscal Year 2017: Dr. John K. Paglia total compensation $63,162.
2018-12-31 DR. JOHN K. PAGLIA has been a Director of the Company since December 3, 2014. Dr. Paglia holds a Ph.D. in finance, an MBA, a B.S. in finance, and is a Certified Public Accountant and Chartered Financial Analyst. In 2000, Dr. Paglia joined the faculty of Pepperdine University Graziadio School of Business where he is now Senior Associate Dean and Professor of Finance. Dr. Paglia has held a number of leadership positions at Pepperdine including Director of the Pepperdine Private Capital Markets Project, Director of Accreditation, Department Chair for Accounting and Finance, Associate Dean for Fully Employed Programs, Executive Director for the Peate Institute for Entrepreneurship, and currently oversees the business school faculty in his role as Senior Associate Dean. For his groundbreaking research on the private capital markets, Dr. Paglia was honored by the National Association of Certified Valuators and Analysts with the “Industry Titan” Award in 2016, the Alliance for Mergers & Acquisitions Advisors and Grant Thornton with a “Thought Leader of the Year Award” in 2012, and the Association for Corporate Growth with an “Excellence in M&A Award” in 2011. In 2016, Dr. Paglia was also awarded with a contract with the Library of Congress as a private equity and venture capital expert to conduct research on the economic impacts of the Small Business Administration’s SBIC private equity program. Dr. Paglia’s knowledge of technical accounting issues and business experience qualify him as an expert in financial matters and makes him a qualified candidate for the Board.
2019-12-30 DR. JOHN K. PAGLIA has been a Director of the Company since December 3, 2014. ... Director Compensation for Fiscal Year 2019: Dr. John K. Paglia total compensation $200,200.
2020-12-29 DR. JOHN K. PAGLIA has been a Director of the Company and Chair of the Audit Committee since December 3, 2014. He is also a Director and Audit & Finance Committee Chair for Cal-X Business Accelerator, Inc. (with 30 regenerative health technology startups); Director for the non-profit California Amateur Hockey Association; and Senior Associate Dean and Professor of Finance at Pepperdine University. Dr. Paglia holds a Ph.D. in finance, an MBA, a B.S. in finance, and is a Certified Public Accountant, Chartered Financial Analyst, Financial Risk Manager, and is NACD Directorship Certified™ by the National Association of Corporate Directors. He has held a number of leadership positions at Pepperdine University since joining the faculty in 2000, including Founding Director of the Pepperdine Private Capital Markets Project, Director of Accreditation, Department Chair for Accounting and Finance, Associate Dean for Part-time Programs, Executive Director for the Peate Institute for Entrepreneurship, and currently oversees the business school faculty in his role as Senior Associate Dean. For his groundbreaking research on the private capital markets, he was honored by the National Association of Certified Valuators and Analysts with the “Industry Titan” Award in 2016, the Alliance for Mergers & Acquisitions Advisors and Grant Thornton with a “Thought Leader of the Year Award” in 2012, and the Association for Corporate Growth with an “Excellence in M&A Award” in 2011. In 2016, he was also awarded with a contract with the Library of Congress as a private equity and venture capital expert to conduct research on the economic impacts of the Small Business Administration’s SBIC private equity program. In 2019 he was called on by the U.S. House of Representatives Committee on Small Business to provide expert congressional testimony during the hearing: SBA Management Review: Small Business Investment Company Program. We believe his knowledge of technical accounting issues and business experience qualify him as an expert in financial matters and as a qualified candidate for the Board.
2021-05-11 Dr. John K. Paglia 2020 95,250 116,336 57,980 – 269,566 ...On July 17, 2020, the Board reviewed and approved the Nominating Committee’s recommendation to grant its non-employee directors non-qualified options to purchase common stock (“stock options”) taking into consideration market standards and the growth of the business. Options granted were; 5,000 each to Dr. John Paglia...Stock options vest and become exercisable as follows: (i) no option shares will be vested prior to the grant date; and (ii) the balance of the option shares will vest annually on their anniversary date, 40% the first year, 30% the second and 30% the final year measured from the grant date, provided that there has not been a termination of service.
2021-12-17 DR. JOHN K. PAGLIA, a recipient of several prestigious honors for his work on the financing and capital markets, has been a Director of the Company and Chair of the Audit Committee since December 3, 2014. ... The Board has three committees: Audit Committee, Compensation Committee, and Nominating & Corporate Governance Committee. ... Audit Committee members during fiscal year 2021: Dr. John K. Paglia (Chair). ... Compensation Committee members during fiscal year 2021: John K. Paglia. ... Director Compensation for Fiscal Year 2021: Dr. John K. Paglia total compensation $167,891.
2022-12-23 Dr. John K. Paglia, a recipient of several prestigious honors for his work in the financing and capital markets space, has been a director of the Company and Chair of the Audit Committee since December 3, 2014. ... Audit Committee members during fiscal year 2022: Dr. John K. Paglia (Chair), Dr. Lisa LaVange, Sharlene Evans. ... Compensation Committee members during fiscal year 2022: Dr. Daniel Weiner (Chair), Dr. Lisa LaVange, Sharlene Evans. ... Nominating & Corporate Governance Committee members during fiscal year 2022: Dr. Lisa LaVange (Chair), Dr. Daniel Weiner, Dr. John K. Paglia. ... Director Compensation Table: Dr. John K. Paglia total compensation $145,054.
2023-12-22 Dr. John K. Paglia, a recipient of several prestigious honors for his work in the financing and capital markets space, has been a director of the Company and Chair of the Audit Committee since December 3, 2014. ... Dr. Paglia holds a Ph.D. in finance from the University of Kentucky, an MBA from Gannon University, a B.S. in finance from Gannon University, and is a Certified Public Accountant, Chartered Financial Analyst, and is NACD Directorship Certified™.
2024-12-23 DR. JOHN K. PAGLIA, a recipient of several prestigious honors for his work in the financing and capital markets space, has been a director of the Company and Chair of the Audit Committee since December 3, 2014. ... The Board has three committees: Audit Committee, Compensation Committee, and Nominating & Corporate Governance Committee. ... The table below shows all compensation awarded to, earned by or paid to our non-employee directors during the fiscal year 2024: Dr. John K. Paglia 2024 80,000 120,071 200,071.

Data sourced from SEC filings. Last updated: 2026-03-05